NeOnc Ignites Explosive Summer: 4 New Research Reports + UAE/Dubai Drug Approval Fuel Breakout Momentum
NeOnc Technologies Holdings (NASDAQ: NTHI) has received two Investigational New Drug (IND) authorizations from the UAE Health Department, expanding international clinical development for its lead CNS cancer drugs NEO100 and NEO212. The approvals cover multiple clinical protocols including pediatric pathways. NeOnc expects topline Phase 2a data for …